Nanosphere, Inc. Receives FDA Clearance for Nano-Enabled Molecular Diganostic Platform and Approval for Warafin Sensitivity Testing

Sep 18, 2007

Nanosphere, Inc., announced this month that it received FDA clearance for its Verigene® System, a random access, molecular diagnostics workstation that uses gold nanoparticle probe technology for nucleic acid and protein diagnostics. This is the first nano-enabled medical diagnostics test cleared by the FDA. According to the diagnostics company, “ easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform.” Nanosphere, Inc. also received FDA approval for the first genetic test of the Verigene® System for warafin sensitivity.

↑ Back to Nano World Breaking News™

↑ Back to Nano World News™

RSS feed